Creekmur Asset Management LLC Cuts Position in DaVita Inc. (NYSE:DVA)

Creekmur Asset Management LLC cut its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 24.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,720 shares of the company's stock after selling 2,132 shares during the period. Creekmur Asset Management LLC's holdings in DaVita were worth $1,005,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. SBI Securities Co. Ltd. purchased a new stake in DaVita in the fourth quarter valued at about $41,000. Quarry LP purchased a new position in shares of DaVita in the 3rd quarter valued at approximately $60,000. Venturi Wealth Management LLC boosted its stake in DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after purchasing an additional 152 shares in the last quarter. Versant Capital Management Inc grew its position in DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after purchasing an additional 169 shares during the last quarter. Finally, Blue Trust Inc. grew its position in DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock worth $76,000 after purchasing an additional 131 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company's stock.

Analyst Ratings Changes

Several research firms have recently commented on DVA. Barclays lifted their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 18th. StockNews.com lowered DaVita from a "buy" rating to a "hold" rating in a research note on Wednesday. Sanford C. Bernstein set a $184.00 price target on DaVita in a research note on Friday, February 21st. Finally, Cowen restated a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, DaVita presently has an average rating of "Hold" and a consensus target price of $166.33.

Remove Ads

DaVita Stock Performance

DVA traded down $4.37 during midday trading on Friday, hitting $149.37. 1,009,511 shares of the company were exchanged, compared to its average volume of 811,855. The company's 50 day simple moving average is $155.75 and its 200 day simple moving average is $157.28. The firm has a market capitalization of $11.95 billion, a price-to-earnings ratio of 13.91, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, sell-side analysts predict that DaVita Inc. will post 10.76 earnings per share for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.